益佰制药预计2025年度归属净利润为负值

Core Viewpoint - Yibai Pharmaceutical (600594) announced that it expects a negative net profit for the fiscal year 2025, indicating an anticipated operational loss for the year [1] Financial Performance - The company’s financial department has conducted preliminary calculations, leading to the expectation of a loss in 2025 [1] - Yibai Pharmaceutical will adhere to the Shanghai Stock Exchange listing rules and expedite its financial accounting process [1] Future Disclosure - The company commits to disclosing the 2025 annual performance forecast within the stipulated timeframe [1] - The final financial data will be based on the officially disclosed audited annual report for 2025 [1]